Literature DB >> 6156064

Alcoholic liver disease. Absence of alpha-fetoprotein elevations in the recovery phase.

T E Noble, J Galdabini, R M Resnik, E Alpert.   

Abstract

Serum alpha-fetoprotein (AFP) may be detected in patients with nonneoplastic liver diseases such as massive hepatic necrosis, viral hepatitis, and experimental liver injury, AFP levels have not been serially assessed in patients with alcoholic liver disease, with or without cirrhosis, during the period following cessation of alcohol. Thirty-two such patients were studied with weekly AFP determinations, an average of five such measurements being obtained per patient. The severity of alcoholic liver disease in this group varied from mild alcoholic hepatitis to advanced cirrhosis, and overall mortality was 31%. Thirty-one of the 32 patients had consistently negative AFP determinations. One patient with persistently elevated AFP levels proved to have hepatoma at autopsy. This study failed to detect AFP evelations in a group of patients with alcoholic liver disease and suggests that positive AFP determinations in such patients shoudl raise the question of underlying hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156064     DOI: 10.1007/BF01308513

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

1.  Preliminary observations of d-penicillamine therapy in acute alcoholic liver disease.

Authors:  R H Resnick; J Boitnott; F L Iber; H Makopour; J J Cerda
Journal:  Digestion       Date:  1974       Impact factor: 3.216

2.  Hepatocyte proliferation and alpha 1-fetoprotein in pregnant, neonatal, and partially hepatectomized rats.

Authors:  S Sell; M Nichols; F F Becker; H L Leffert
Journal:  Cancer Res       Date:  1974-04       Impact factor: 12.701

3.  Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis.

Authors:  G G Karvountzis; A G Redeker
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

4.  Natural history of alcoholic hepatitis. 3. Histological changes.

Authors:  J T Galambos
Journal:  Gastroenterology       Date:  1972-12       Impact factor: 22.682

5.  Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial.

Authors:  H P Porter; F R Simon; C E Pope; W Volwiler; L F Fenster
Journal:  N Engl J Med       Date:  1971-06-17       Impact factor: 91.245

6.  Natural history of alcoholic hepatitis. I. The acute disease.

Authors:  M W Lischner; J F Alexander; J T Galambos
Journal:  Am J Dig Dis       Date:  1971-06

7.  Serum alpha-fetoprotein: diagnostic significance in liver disease.

Authors:  E Ruoslahti; M Salaspuro; H Pihko; L Andersson; M Seppälä
Journal:  Br Med J       Date:  1974-06-08

8.  alpha-fetoprotein in noneoplastic hepatic disorders.

Authors:  J R Bloomer; T A Waldmann; K R McIntire; G Klatskin
Journal:  JAMA       Date:  1975-07-07       Impact factor: 56.272

9.  Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis.

Authors:  E Alpert; E R Feller
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.